Anova is realizing the promise of precision medicine, helping patients access promising investigational products wherever they receive care.
The world’s clinical development environment, at your fingertips
Our AnovaOS™ technology platform provides an integrated research network of 15k sponsors, 130k active studies, 15k investigational products, 44k+ research sites, and 100k+ investigators. We bring the world’s clinical research environment together for every treating physician.
The goal is to provide meaningful access, making all studies available to every research site. Treating physicians and research staff can efficiently match patients to promising new treatments, secure access and quickly enroll the patient to a clinical trial or compassionate use program. Direct access to key decision-makers at manufacturers enables just-in-time access to any investigational product.
AnovaOS™ is the catalyst that accelerates development of complex treatments for oncology, infectious disease, neurology, immunology, cardiology and rare disease.
Anova is realizing the promise of precision medicine, helping patients access promising investigational products wherever they receive care.
The world’s clinical development environment, at your fingertips
Our AnovaOS™ technology platform provides an integrated research network of 4k sponsors, 130k active studies, 15k investigational products, 40k+ research sites, and 100k+ investigators. We bring the world’s clinical research environment together for every treating physician.
The goal is to provide meaningful access, making all studies available to every research site. Treating physicians and research staff can efficiently match patients to promising new treatments, secure access and quickly enroll the patient to a clinical trial or compassionate use program. Direct access to key decision-makers at manufacturers enables just-in-time access to any investigational product.
AnovaOS™ is the catalyst that accelerates development of complex treatments for oncology, infectious disease, neurology, immunology, cardiology and rare disease.
Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.
Our technology platform, AnovaOS™, enables sponsors and sites/physicians to connect, complete study feasibility, match patients to any study, activate and enrol patients just-in-time to any clinical trial, or apply for compassionate use of any of investigational product. Sponsors can access regulatory packages for streamlined submission and approval, collect quality data, monitor studies and integrate research pathways to accelerate development.
Active Studies 
Match any patient to any study, streamline activation & enrolment. Initiate data capture.
Sponsors 
Connect with sponsors, globally.
Investigational 
Products
Deliver meaningful access to investigational treatments through clinical trial or compassionate use.
Investigators 
Find and connect with qualified investigators. Capture essential documents and improve compliance.
Research Sites 
Find and connect with sites and physicians. Undertake feasibility, activate and enrol patients just-in-time.
Anova is a technology company bringing participants in the clinical research process together to speed promising new treatments to market, at reduced cost and for a larger number of patients. We kickstart the development of new treatments through standardization and automation as no one else can do.
Our technology platform, AnovaOS™, enables sponsors and sites/physicians to connect, complete study feasibility, match patients to any study, activate and enrol patients just-in-time to any clinical trial, or apply for compassionate use of any of investigational product. Sponsors can access regulatory packages for streamlined submission and approval, collect quality data, monitor studies and integrate research pathways to accelerate development.
Sponsor & study registry
All sponsors and active studies are captured globally. Protocols are structured and eligibility criteria codified to match to patient clinical characteristics. Direct access to sponsor program leads provided for rapid activation and enrolment.
Site & physician qualification
Qualified site and personnel profiles captured with all research interests, regulatory credentials and operational capabilities readily available for site feasibility and qualification.
Patient matching
Patients matched to any of 130k+ active studies and 15k+ investigational products in development globally. Site capabilities, physician credentials, and patient clinical criteria used to match to studies. Just-in-time application for clinical trials or compassionate use enabled for all sponsors, all studies, all investigational products, and for all patients
Study activation & enrolment
Activate sites in 5 working days using master contract and fee schedule, with streamlined regulatory compliance.
Data capture and evidence generation
Integrated data capture and clinical evidence generation across product and indications.
Sponsor & study registry
All sponsors and active studies are captured globally. Protocols are structured and eligibility criteria codified to match to patient clinical characteristics. Direct access to sponsor program leads provided for rapid activation and enrolment.
Site & physician qualification
Qualified site and personnel profiles captured with all research interests, regulatory credentials and operational capabilities readily available for site feasibility and qualification.
Patient matching
Patients matched to any of 130k+ active studies and 15k+ investigational products in development globally. Site capabilities, physician credentials, and patient clinical criteria used to match to studies. Just-in-time application for clinical trials or compassionate use enabled for all sponsors, all studies, all investigational products, and for all patients
Study activation & enrolment
Activate sites in 5 working days using master contract and fee schedule, with streamlined regulatory compliance.
Data capture and evidence generation
Integrated data capture and clinical evidence generation across product and indications.
“The South Sound Care Foundation supports providers across the South Sound region access targeted therapies for patients with cancer. Anova has been instrumental in helping our team establish a robust compassionate use program and providing the technology required to deliver seamless and compliant compassionate use for our providers.”
“Anova and ERC crafted an ethical Right-to-Try program that has helped patients with brain tumors and generated survival data that has became integral to our regulatory submissions. When we secure marketing approval it will be, in part, due to our partnership with Anova.”
“Anova’s forward-thinking approach to Expanded Access has brought Celularity investigational products to cancer and COVID-19 patients in need while generating data that has directly impacted our traditional development efforts.”
“OPN Healthcare is a specialty healthcare services company focused on cancer care, with over 1 million covered lives. Our partnership with Anova has been helped us to establish a robust clinical research program across our practices in southern California and improve access to promising new treatments for our patients. Within our first six months of operation we have recruited dozens of patients into clinical trials and the program is continuing to grow rapidly.”
“Anova’s deep regulatory and technical expertise has helped our company navigate conflicts that can (and do) arise with traditional CRO partners. Ethical research that complies with regulatory requirements is a foundation of our work. On multiple occasions, Anova has recommended a path that has been validated by regulators to be the best approach for our company and our products for patients with herpes and COVID-19.”
“Anova’s forward-thinking approach to Expanded Access has brought Celularity investigational products to cancer and COVID-19 patients in need while generating data that has directly impacted our traditional development efforts.”
“Anova and ERC crafted an ethical Right-to-Try program that has helped patients with brain tumors and generated survival data that has became integral to our regulatory submissions. When we secure marketing approval it will be, in part, due to our partnership with Anova.”
“Anova’s deep regulatory and technical expertise has helped our company navigate conflicts that can (and do) arise with traditional CRO partners. Ethical research that complies with regulatory requirements is a foundation of our work. On multiple occasions, Anova has recommended a path that has been validated by regulators to be the best approach for our company and our products for patients with herpes and COVID-19.”
“OPN Healthcare is a specialty healthcare services company focused on cancer care, with over 1 million covered lives. Our partnership with Anova has been helped us to establish a robust clinical research program across our practices in southern California and improve access to promising new treatments for our patients. Within our first six months of operation we have recruited dozens of patients into clinical trials and the program is continuing to grow rapidly.”
“The South Sound Care Foundation supports providers across the South Sound region access targeted therapies for patients with cancer. Anova has been instrumental in helping our team establish a robust compassionate use program and providing the technology required to deliver seamless and compliant compassionate use for our providers.”
